Janssen Beats Untimely Calif. Appeal Over Risperdal Death
By Dani Kass ( March 24, 2017, 6:10 PM EDT) -- A mother whose son died during a clinical study of Janssen Pharmaceuticals' antipsychotic medication Risperdal waited too long to appeal certain claims that had been dismissed in her wrongful death suit against the company — which on different claims won her $5.6 million — a California appeals court said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.